Table 2 Descriptive statistics of the two cohorts (pre- and post- course) included in the study
Pre-course (n = 15) | Post-course (n = 15) | |
|---|---|---|
Age at diagnosis (years) | 68 (59–72) | 63 (59–70) |
PSA at baseline MR (ng/ml) | 7.75 (5.6–8.9) | 6.04 (5.2–10.3) |
Prostate volume at baseline MR (cc) | 42.1 (37–56.2) | 53.3 (32.7–80.3) |
PSA density at baseline MR (ng/ml/ml) | 0.16 (0.1–0.24) | 0.13 (0.1–0.17) |
Gleason score at entry biopsy | ||
3 + 3 | 14 [93] | 10 [67] |
3 + 4 | 1 [7] | 5 [22] |
Gleason score at confirmatory biopsy | ||
3 + 3 | 3 [20] | 10 [67] |
3 + 4 | 8 [53] | 4 [26] |
4 + 3 | 3 [20] | 1 [7] |
4 + 4 | 1 [7] | – |
Baseline highest PI-RADS score | ||
2 | 1 [7] | 2 [13] |
3 | 6 [40] | 6 [40] |
4 | 8 [53] | 7 [47] |
5 | – | – |
Follow up highest PI-RADS score | ||
2 | 1 [7] | 3 [20] |
3 | 2 [13] | 4 [26] |
4 | 10 [67] | 6 [40] |
5 | 2 [13] | 2 [14] |
PRECISE score | ||
1 | – | – |
2 | 1 [7] | – |
3 | 2 [13] | 10 [67] |
4 | 10 [67] | 4 [26] |
5 | 2 [13] | 1 [7] |